EMD Serono assigns operational changes.
EMD Serono, a subsidiary of Merck KGaA, reported the appointments of Gary Zieziula as COO, Allene Diaz as senior vice-president of Managed Markets, Lisa Buffington as vice-president of US Communications, Alexander Kuta as vice-president and head of US Regulatory Affairs, and Michael Ruggiero as vice-president of US Government Affairs and Policy.
Zieziula is responsible for increasing the growth of the US organization by controlling the performance of EMD franchises.
Diaz is responsible for developing and executing Managed Markets marketing, sales, and contracting strategies for EMD Seronoproducts.
Buffington is responsible for executing all aspects of the company’s communications strategy, including external and employee communications, media relations, corporate reputation, product communications, community relations, as well as meetings and events.
Kuta is responsible for the strategic direction of EMD Serono’s regulatory efforts with the FDA, overseeing regulatory submissions in the US and strengthening interactions with the FDA.
Ruggiero is responsible for federal and state legislative, policy, political, and advocacy strategy and execution for EMD Serono’s business.
Source: EMD Serono
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.